Navigation Links
Cetero Research Seminars Provide Insights on Designing Accelerated Proof-of-Concept Studies
Date:4/20/2011

CARY, N.C., April 20, 2011 /PRNewswire/ -- Cetero Research, the leading early-phase contract research organization (CRO), will present a scientific seminar series for pharmaceutical and biotechnology researchers entitled "Practical Insights for Designing and Conducting an Accelerated Proof-of-Concept Program." The seminars, the continuation of a series that occurred in the fall of 2010, will share best practices on how to run successful studies by developing robust protocols, ensuring safety and recruiting effectively for innovative accelerated proof-of-concept study designs. The six-city tour will kick off on April 28 in Bridgewater, NJ.

"Pharmaceutical and biotechnology companies are very interested in the efficiencies that this approach can bring to their early-phase clinical studies. However, there are a number of complexities involved in developing these studies to successfully combine multiple protocols into a single study," said Troy W. McCall, Ph.D., Chief Executive Officer of Cetero Research. "Cetero leadership and independent industry experts will share case studies and best practices."

The scientific sessions will cover three aspects of Accelerated Proof-of-Concept (AcPOC) study design and conduct: protocol development, safety in first-in-human trials and patient recruitment strategies. The seminars will offer real-world advice on creating studies that strike a balance between the strict schedule to which accelerated studies must adhere and the built-in flexibility that these trials require for troubleshooting, efficiency and regulatory approval.

"With the accelerated approach, the protocol must be a living document that can be adjusted as you move through each component of the study. There needs to be flexibility in adapting to feedback from regulators and reactions from participants," said Alan Copa, PharmD, President, Clinical Operations - Fargo for Cetero Research. "With the increasing demand for this type of study, it is important to discuss the best practices that will ensure the most efficient, robust study design possible."

Each seminar will last two hours and include three presentations as well as a question and answer session. The series schedule is as follows:

  • Thursday, April 28 — Bridgewater, NJ
  • Wednesday, May 4 — Northbrook, IL
  • Tuesday, May 10 — King of Prussia, PA
  • Wednesday, May 11 — Cambridge, MA
  • Tuesday, May 17 — La Jolla, CA
  • Wednesday, May 18 — San Jose, CA

The Cetero sessions are complimentary, but pre-registration is required. For more information about the series or to register for a session, please email rsvp@cetero.com, visit http://www.cetero.com/acpocseminar/spring or call 877-7CETERO.

About Cetero Research

Cetero Research, the leading early-phase contract research organization (CRO), has conducted more than 20,000 clinical pharmacology studies, more than any other CRO. With facilities across North America, Cetero offers flexible, high-quality clinical development services in a range of therapeutic areas, including asthma and allergy, dermatology and diabetes, as well as bioanalytical services to support clinical, preclinical drug and biomarker analysis for small and large molecules. It uses innovative approaches, such as the Accelerated-Proof-of-Concept study design, to provide key decision-making data earlier in the development process. A pioneer in the pharmaceutical and biotechnology space, Cetero prioritizes ensuring the safety of its patient and normal healthy study participants, reporting high-quality, reliable data and providing on-time results. For more information, visit www.cetero.com or call 877.7CETERO.


'/>"/>
SOURCE Cetero Research
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cetero Research Announces Completion of 20,000th Early-Phase Clinical Study
2. Cetero Research Names Dr. Roger Hayes President of Bioanalytical Operations
3. Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
4. Cetero Research Leads Industry in Human Allergy Models
5. Premier Research Re-brands its Medical Device Business Unit to D-TARGET
6. Australian Center Readies Brain Research Program for Addition of Elekta MEG System
7. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
8. Thorne Research and Integrative Health Resources Establish Joint Venture to Provide Full Range of Services in Practice Development, Patient and Clinician Education, and Access to Nutritional Supplements in Integrative Medicine
9. New Research Links Restless Legs Syndrome (RLS) to Cardiovascular Disease
10. Kanzius Cancer Research Foundation Earns $1 for Each New Facebook Fan
11. Phase I Research of Extended-Release Topiramate Shows Less Fluctuation in Plasma Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017 ... presentations and one poster presentation at PittCon ... Chicago IL.  Pittcon is the world,s largest ... science and serves a wide array of ... sciences, pharmaceutical discovery and QA, food safety, ...
(Date:2/23/2017)... This report analyzes analyzes the worldwide markets for Wound Debridement Products ... the US, Canada , Japan ... , Latin America , and Rest ... period 2015 through 2022. Also, a six-year historic analysis is ... from primary and secondary research. Company profiles are primarily based ...
(Date:2/23/2017)... NEW YORK , Feb. 22, 2017 Mixed ... The mixed tocopherols market is projected to reach ... from 2016. The market is driven by factors such as ... & beverages and in feed, and regulations for sourcing, processing, ... for mixed tocopherols from emerging markets such as the ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... (PRWEB) February ... for the nation to come together to combine its favorite ... with its favorite fruit – apples! To celebrate National Nutrition ... join the “Apple Madness” bracket tournament – a five-week, five-round ...
(Date:2/23/2017)... ... 23, 2017 , ... Thomas Vas-Don suffered from severe injury due ... was able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ... the principals of massage, anatomy , trigger points and referral pain patterns ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... in recent years. The technology is so cutting edge, in fact, the U.S. ... for stem cell procedures. However, successful patient outcomes in certain clinical stem cell ...
(Date:2/22/2017)... ... February 22, 2017 , ... Giving patients with diabetes ... emergency room, fewer hospital admissions, and better blood pressure and glycemic control, a ... The study can be found here . , The study comes as ...
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the World Horse ... host Tom Seay and his production crew. Tom Seay’s program “Best of America ... world. Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, ...
Breaking Medicine News(10 mins):